List of works - Lorenzo Arnaboldi

Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection

scientific article published on 18 August 2010

Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin.

scientific article published on January 2015

Cyclosporine A impairs the macrophage reverse cholesterol transport in mice by reducing sterol fecal excretion

scientific article

Direct effects of statins on the vascular wall

scientific article published on 01 May 1998

Direct vascular effects of HMG-CoA reductase inhibitors

scientific article published on 01 April 1998

Do structural differences in statins correlate with clinical efficacy?

scientific article published on August 2010

Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation.

scientific article published in December 2001

Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes

scientific article published on 01 January 1996

Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits.

scientific article published on 20 November 2008

Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells.

scientific article published on 16 July 2009

Free cholesterol alters macrophage morphology and mobility by an ABCA1 dependent mechanism

scientific article published in March 2011

Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency.

scientific article published on 10 November 2009

Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.

scientific article

Nitric oxide-donating atorvastatin attenuates neutrophil recruitment during vascular inflammation independent of changes in plasma cholesterol

scientific article published on 01 June 2013

Oxidized LDL-dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy

scientific article published on 02 August 2021

Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation

scientific article published on 16 September 2007

Statins effect on smooth muscle cell proliferation.

scientific article

List of works by Lorenzo Arnaboldi

Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection

Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin.

Cyclosporine A impairs the macrophage reverse cholesterol transport in mice by reducing sterol fecal excretion

Direct effects of statins on the vascular wall

Direct vascular effects of HMG-CoA reductase inhibitors

Do structural differences in statins correlate with clinical efficacy?

Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation.

Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes

Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits.

Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells.

Free cholesterol alters macrophage morphology and mobility by an ABCA1 dependent mechanism

Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency.

Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.

Nitric oxide-donating atorvastatin attenuates neutrophil recruitment during vascular inflammation independent of changes in plasma cholesterol

Oxidized LDL-dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy

Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation

Statins effect on smooth muscle cell proliferation.